Atropine
No admixture requiredFull monograph review pending
U.S. label preparation
Atropine sulfate (Hospira syringes) · No admixture required
- Preparation
- Hospira single-dose IV syringes contain a prepared solution. Confirm the specific concentration (0.05 or 0.1 mg/mL) and calculate the volume for the indication.
- Administration and handling
- Inspect the solution and seal before use. Discard unused drug. For adult symptomatic bradycardia with a pulse, see the linked AHA algorithm in the medication record.
Product and source details
Hospira, Inc. · NDA021146
Product NDC: 0409-1630, 0409-9630, 0409-4910, 0409-4911
SPL effective 2026-05-18 | SPL version 31. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Safety resources for this medication (1)
- AHA adult bradycardia with a pulse algorithm (2025) (opens in a new tab)
Source date and scope
Status date: 2025
Status in that table: Published guideline algorithm
Exact table location: Adult Bradycardia With a Pulse Algorithm; atropine IV dose box
Scope: Adults with bradycardia and a pulse. Check symptoms, perfusion and the presence of a pulse before selecting an algorithm.
Interpretation: The selected product label describes several indications. Apply the algorithm for the actual clinical scenario.
Read the linked communication and current prescribing information before use. Resource dates and affected product scopes differ; a listed resource is not a full monograph or a lot-specific clearance.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.